Bomin Electronics (603936.SH) granted 15.14 million restricted shares and 5.24 million share options to incentive objects.
Bomin Electronics (603936.SH) announced that, in accordance with the regulations of the Bomin Electronics 2026 Restricted Stock and Stock Option Incentive Plan and the authorization of the company's first extraordinary general meeting of shareholders in 2026, the company's board of directors believes that the grant conditions for the first grant of the incentive plan have been met and has agreed to designate April 3, 2026 as the first grant date. The company will grant 15.14 million restricted shares to 165 eligible incentive recipients at a price of 6.75 yuan per share, and will grant 5.24 million stock options to 46 eligible incentive recipients with an exercise price of 10.80 yuan per option.
Bomin Electronics (603936.SH) announced that, in accordance with the provisions of the "Bomin Electronics 2026 Restrictive Stock and Stock Option Incentive Plan" and the authorization of the company's first extraordinary general meeting of shareholders in 2026, the board of directors believes that the conditions for the first grant under the incentive plan have been met. It was agreed to designate April 3, 2026 as the first grant date, granting 15.14 million restricted shares to 165 eligible incentive recipients at a price of 6.75 yuan per share. Additionally, 4.24 million stock options were granted to 46 eligible incentive recipients at an exercise price of 10.80 yuan per option.
Related Articles

Two big events on the eve of SpaceX's listing: Starship test flight postponed, IPO bundled with Grok AI sparking discussions.

Boji Medical Technology (300404.SZ) subsidiary Danyuan Diabetic Ointment has obtained the approval notice for drug clinical trials.

Evening hot topics on A-share market | Nine government departments jointly issued a document with 64 measures to boost consumption!
Two big events on the eve of SpaceX's listing: Starship test flight postponed, IPO bundled with Grok AI sparking discussions.

Boji Medical Technology (300404.SZ) subsidiary Danyuan Diabetic Ointment has obtained the approval notice for drug clinical trials.

Evening hot topics on A-share market | Nine government departments jointly issued a document with 64 measures to boost consumption!

RECOMMEND

Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026

Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026

Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026


